Caring for two in the ICU: Pharmacotherapy in the critically ill pregnant patient
- 1 April 2023
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 43 (5) , 403-418
Abstract
Safe and thoughtful medication management of pregnant patients requiring intensive care unit (ICU) level of care is key to optimizing outcomes for both mother and fetus. Pregnancy induces physiologic alterations that closely mirror the changes expected in a critically ill patient. These changes can be predictable depending on the gestational age and trimester and will directly impact the pharmacokinetic profile of medications commonly used in the ICU; examples include decreased gastric emptying, increased blood and plasma volume, increased glomerular filtration, and increased cardiac output. When pregnant patients require ICU care, the resulting impact on drug absorption, distribution, metabolism, and elimination can be difficult to predict. In addition, there are many nuances of medication metabolism and interface with the placental barrier that should be considered when selecting pharmacotherapy for the pregnant patient. Critical care clinicians need to be aware of medication interactions with the placenta and weigh the risk versus benefit profile of medication use in this patient population. Obstetric critical care admissions have increased over the years, especially during the coronavirus waves. Therefore, understanding the interplay between pregnancy and critical illness to optimize pharmacotherapy selection is crucial to improving health outcomes of mother and fetus. This review highlights pharmacotherapy considerations in the pregnant ICU patient for the following topics: physiologic alterations, categorizing medication risk, supportive care, sepsis, cardiogenic shock, acute respiratory distress syndrome, and venous thromboembolism.Keywords
This publication has 140 references indexed in Scilit:
- The Safety of Histamine 2 (H2) Blockers in Pregnancy: A Meta-analysisDigestive Diseases and Sciences, 2008
- Once-daily Dosing of Gentamicin in Obstetrics and GynecologyClinical Obstetrics and Gynecology, 2008
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomesObstetrics & Gynecology, 2001
- Pregnancy and the lungsPostgraduate Medical Journal, 2000
- Prevention of Fetal and Maternal Cyanide Toxicity from Nitroprusside with Coinfusion of Sodium Thiosulfate in Gravid EwesAnesthesia & Analgesia, 1997
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancyAmerican Journal of Obstetrics and Gynecology, 1995
- Effects of α- and β-adrenergic agonists on intramammary pressure and milk flow in dairy cowsJournal of Dairy Research, 1991
- Effect of pregnancy on gastrointestinal transitDigestive Diseases and Sciences, 1982